Archive for 2005

Merck Outlines Vioxx Defense

Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog